Recurrent Carotid Stenosis

Completed

Phase 2 Results

Results

Greater than 50 percent restenosis developed in 11 operated vessels (16%) of the treated group and in 10 arteries (14%) of the placebo group. By intention-to-treat analysis, greater than 50% restenosis developed in 16 of 90 operated vessels in treated patients and in 10 of 85 arteries in patients receiving placebo. Similar differences were observed for greater than 20 percent restenosis and for the comparison of patients rather than operated vessels by either intention-to-treat or efficacy analyses.